Efficacy and Safety Assessment of T2345 in Ocular Hypertensive or Glaucomatous Patients

• Status: Completed
• Trial end date: 2010-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to assess the efficacy and safety of T2345 versus active comparator.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Laboratoires Thea

Criteria

Inclusion Criteria:

• Adult patients diagnosed with glaucoma

Exclusion Criteria:

• Under 18.